诊疗知识库_医脉通

慢性粒细胞白血病 - 参考文献

概览: 简介; 名称与编码; 精要; 历史; 致谢; 缩略语表

基础: 定义; 流行病学; 病因; 病理解剖; 病理生理; 分类分型

预防: 预防; 筛检

诊断: 问诊与查体; 疾病演变; 辅助检查; 并发症; 诊断标准; 诊断程序; 鉴别诊断

治疗: 治疗目标; 治疗细则; 管理与监测; 治疗程序; 治疗进展; 护理与照顾

随访: 随访要点; 预后; 患者教育

临床资料: 诊疗指南; 临床路径; 病例; 临床问题

文献资料: 参考文献; 网络资源; 推荐文献; 课件; 图片

聚合阅读>>

参考文献

流行病学

[1]	张之南，杨天楹，郝玉书，等，血液病学，人民卫生出版社，2003，10：822-825.

病因

[1]	Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002. 100(7): 2292-302.
	pubmed摘要 \| 全文链接 \| PDF全文

[2]	Duarte-Davidson R, Courage C, Rushton L, Levy L. Benzene in the environment: an assessment of the potential risks to the health of the population. Occup Environ Med. 2001. 58(1): 2-13.
	pubmed摘要 \| 全文链接 \| PDF全文

诊断程序

[1]	《World Health Organization Classification of Tumors. Pathology and Genetic of Tumors of Haematopoietic and Lymphoid Tissue》（2008）

[2]	《血液病诊断及疗效标准》（张之南、沈悌主编，科学出版社，2008年，第三版）

Druker BJ,Guilhot F,O'Brien SG,Gathmann I,Kantarjian H,Gattermann N,Deininger MW,Silver RT,Goldman JM,Stone RM,Cervantes F,Hochhaus A,Powell BL,Gabrilove JL,Rousselot P,Reiffers J,Cornelissen JJ,Hughes T,Agis H,Fischer T,Verhoef G,Shepherd J,Saglio G,Gratwohl A,Nielsen JL,Radich JP,Simonsson B,Taylor K,Baccarani M,So C,Letvak L,Larson RA. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006 Dec 7. 355(23): 2408-17.

pubmed摘要 | 全文链接

[2]

Cortes JE,Baccarani M,Guilhot F,Druker BJ,Branford S,Kim DW,Pane F,Pasquini R,Goldberg SL,Kalaycio M,Moiraghi B,Rowe JM,Tothova E,De Souza C,Rudoltz M,Yu R,Krahnke T,Kantarjian HM,Radich JP,Hughes TP. Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study. J Clin Oncol. 2010 Jan 20. 28(3): 42

pubmed摘要

[3]	Jabbour E,Cortes JE,Giles FJ,O'Brien S,Kantarjian HM. Current and emerging treatment options in chronic myeloid leukemia. Cancer. 2007 Jun 1. 109(11): 2171-81.
	pubmed摘要 \| 全文链接

[4]	姜志平，陈方平. 伊马替尼治疗慢性粒细胞性白血病耐药机制研究进展[J]．国际输血及血液学杂志，2007;30（2）：１７６

[5]	Branford S,Rudzki Z,Walsh S,Parkinson I,Grigg A,Szer J,Taylor K,Herrmann R,Seymour JF,Arthur C,Joske D,Lynch K,Hughes T. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis. Blood. 2003 Jul 1. 102(1): 276-83.
	pubmed摘要 \| 全文链接